Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment
Claudio L. Bassetti, Antoine Adamantidis, Denis Burdakov, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 9, pp. 519-539
Closed Access | Times Cited: 492

Showing 1-25 of 492 citing articles:

Sleep disorders and cancer: State of the art and future perspectives
Maria P. Mogavero, Lourdes M. DelRosso, Francesco Fanfulla, et al.
Sleep Medicine Reviews (2020) Vol. 56, pp. 101409-101409
Closed Access | Times Cited: 182
Diagnosis of central disorders of hypersomnolence: A reappraisal by European experts
Gert Jan Lammers, Claudio L. Bassetti, Leja Dolenc‐Grošelj, et al.
Sleep Medicine Reviews (2020) Vol. 52, pp. 101306-101306
Open Access | Times Cited: 148
Understanding and approaching excessive daytime sleepiness
Laura Pérez‐Carbonell, Emmanuel Mignot, Guy Leschziner, et al.
The Lancet (2022) Vol. 400, Iss. 10357, pp. 1033-1046
Closed Access | Times Cited: 128
European guideline and expert statements on the management of narcolepsy in adults and children
Claudio L. Bassetti, Ulf Kallweit, Luca Vignatelli, et al.
European Journal of Neurology (2021) Vol. 28, Iss. 9, pp. 2815-2830
Open Access | Times Cited: 115
Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation
Chuan Hong, Noel Byrne, Beata Zamlynny, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 104
Excessive Daytime Sleepiness
Kriti Gandhi, Meghna P. Mansukhani, Michael H. Silber, et al.
Mayo Clinic Proceedings (2021) Vol. 96, Iss. 5, pp. 1288-1301
Open Access | Times Cited: 103
Safety and efficacy of pitolisant in children aged 6 years or older with narcolepsy with or without cataplexy: a double-blind, randomised, placebo-controlled trial
Yves Dauvilliers, Michel Lecendreux, Gert Jan Lammers, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 4, pp. 303-311
Open Access | Times Cited: 94
The integrated brain network that controls respiration
Friedrich Krohn, Manuele Novello, Ruben S. van der Giessen, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 78
Recent advances in treatment for narcolepsy
Lucie Barateau, Yves Dauvilliers
Therapeutic Advances in Neurological Disorders (2019) Vol. 12
Open Access | Times Cited: 84
To split or to lump? Classifying the central disorders of hypersomnolence
Rolf Fronczek, Isabelle Arnulf, Christian R. Baumann, et al.
SLEEP (2020) Vol. 43, Iss. 8
Open Access | Times Cited: 82
European guideline and expert statements on the management of narcolepsy in adults and children
Claudio L. Bassetti, Ulf Kallweit, Luca Vignatelli, et al.
Journal of Sleep Research (2021) Vol. 30, Iss. 6
Open Access | Times Cited: 76
COVID-19: dealing with a potential risk factor for chronic neurological disorders
Tommaso Schirinzi, Doriana Landi, Claudio Liguori
Journal of Neurology (2020) Vol. 268, Iss. 4, pp. 1171-1178
Open Access | Times Cited: 74
Disrupted nighttime sleep and sleep instability in narcolepsy
Kiran Maski, Emmanuel Mignot, Giuseppe Plazzi, et al.
Journal of Clinical Sleep Medicine (2021) Vol. 18, Iss. 1, pp. 289-304
Open Access | Times Cited: 57
Orexin 2 receptor–selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients
Rebecca Evans, Haruhide Kimura, Robert Alexander, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 35
Open Access | Times Cited: 56
Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1
Yves Dauvilliers, Emmanuel Mignot, Rafael del Río Villegas, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 4, pp. 309-321
Closed Access | Times Cited: 40
Large-scale genome sequencing redefines the genetic footprints of high-altitude adaptation in Tibetans
Wangshan Zheng, Yaoxi He, Y. Guo, et al.
Genome biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 37
Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy
Ali Seifinejad, Mergim Ramosaj, Ling Shan, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 19
Open Access | Times Cited: 34
Pediatric sleep: current knowledge, gaps, and opportunities for the future
Alexandria M. Reynolds, Andrea M. Spaeth, Lauren Hale, et al.
SLEEP (2023) Vol. 46, Iss. 7
Open Access | Times Cited: 27
A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD
Rocco Liguori, Vincenzo Donadio, Zerui Wang, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 22
Identification of bidirectional causal links between gut microbiota and narcolepsy type 1 using Mendelian randomization
Dandan Sheng, Peihong Li, Zheng Xiao, et al.
SLEEP (2024) Vol. 47, Iss. 3
Closed Access | Times Cited: 8
Narcolepsy Severity Scale-2 and Idiopathic Hypersomnia Severity Scale to better quantify symptoms severity and consequences in Narcolepsy type 2
Lucie Barateau, Sofiène Chenini, Claire Denis, et al.
SLEEP (2024) Vol. 47, Iss. 5
Closed Access | Times Cited: 8
Interim analysis of a post-authorization safety study of Pitolisant in treating narcolepsy: A real-world European study
Giuseppe Plazzi, Geert Mayer, Ralf Bodenschatz, et al.
Sleep Medicine (2025) Vol. 129, pp. 20-30
Closed Access | Times Cited: 1
Narcolepsy: Beyond the Classic Pentad
Anne Marie Morse, Sooyoung Kim, Shelby Freedman Harris, et al.
CNS Drugs (2025)
Open Access | Times Cited: 1
Therapeutic Use of γ-Hydroxybutyrate: History and Clinical Utility of Oxybates and Considerations of Once- and Twice-Nightly Dosing in Narcolepsy
Thomas Roth
CNS Drugs (2025)
Open Access | Times Cited: 1
Sodium Oxybate: Practical Considerations and Patient Perspectives
Maggie Lavender, Cécile Martin, Diana C. Anderson
CNS Drugs (2025)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top